GAVISCON ANTIACIDE ANTIREFLUX SINGLE DOSE oral suspension 500 mg/10 ml+213 mg/10 ml+325 mg/10 ml

Nombre local: GAVISCON ANTIACIDE ANTIREFLUX SINGLE DOSE Suspension buvable 500 mg/10 ml+213 mg/10 ml+325 mg/10 ml
País: Luxemburgo Luxemburgo
Laboratorio: Reckitt Benckiser Healthcare (Belgium)
Vía: Vía oral
Forma: Suspensión oral
ATC: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) (A02BX)